The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.
Open accessAbstract
Chronic renal disease (CRD) is generally thought to be incurable, except through renal transplantation, and the number of patients with CRD is on the increase. Glomerulosclerosis and tubulointerstitial fibrosis represent the morphological equivalent of end-stage CRD. In this study, we demonstrated the preventive effect of hepatocyte growth factor (HGF) on the progression of renal dysfunction and fibrosis, using a spontaneous mouse model for CRD (ICGN strain). The mice progressively developed glomerular sclerotic injury, tubular atrophy, and renal dysfunction until they were 17 wk of age. When recombinant HGF was injected into these mice during a 4-wk-period (from weeks 14-17 after birth), DNA synthesis of tubular epithelial cells was found to be 4.4-fold higher than in mice without HGF injection, thereby suggesting tubular parenchymal expansion promoted by HGF. Notably, HGF suppressed the expression of transforming growth factor-beta and of platelet-derived growth factor as well as myofibroblast formation in the affected kidney. Consequently, the onset of tubulointerstitial fibrosis was almost completely inhibited by HGF, while HGF attenuated the progression of glomerulosclerosis, both leading to preventing manifestation of renal dysfunction. From our results, supplement therapy with HGF may be taken into consideration as a novel option for prevention and treatment of CRD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Molecular cloning and expression of human hepatocyte growth factor
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., & Shimizu, S. (1989) · Nature · doi:10.1038/342440a0 · Cited by 2,157
Self-citationEpstein, F. H., Brenner, B. M., Meyer, T. W., & Hostetter, T. H. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209093071104 · Cited by 2,075
Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor
Montesano, R., Matsumoto, K., Nakamura, T., & Orci, L. (1991) · Cell · doi:10.1016/0092-8674(91)90363-4 · Cited by 1,146
Self-citationSonnenberg, E., Meyer, D., Weidner, K. M., & Birchmeier, C. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.1.223 · Cited by 698
Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats
Raij, L., Azar, S., & Keane, W. (1984) · Kidney International · doi:10.1038/ki.1984.147 · Cited by 672
Risdon, R. A., Sloper, J. C., & De Wardener, H. E. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90589-8 · Cited by 668
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor
Miyazawa, K., Tsubouchi, H., Naka, D., Takahashi, K., Okigaki, M., Arakaki, N., Nakayama, H., Hirono, S., Sakiyama, O., Takahashi, K., et al. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92316-4 · Cited by 653
Molecular insights into renal interstitial fibrosis.
Eddy, A. A. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7122495 · Cited by 637
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.
Zarnegar, R., & Michalopoulos, G. K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.5.1177 · Cited by 569
Isaka, Y., Fujiwara, Y., Ueda, N., Kaneda, Y., Kamada, T., & Imai, E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116874 · Cited by 529
Lloyd, C. M., Minto, A. W., Dorf, M. E., Proudfoot, A., Wells, T. N. C., Salant, D. J., & Gutierrez-Ramos, J.-C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1371 · Cited by 496
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
Isaka, Y., Brees, D. K., Ikegaya, K., Kaneda, Y., Imai, E., Noble, N. A., & Border, W. A. (1996) · Nature Medicine · doi:10.1038/nm0496-418 · Cited by 482
Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice.
Kawaida, K., Matsumoto, K., Shimazu, H., & Nakamura, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4357 · Cited by 410
Self-citationIshiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K., & Nakamura, T. (1992) · Hepatology · doi:10.1002/hep.1840160520 · Cited by 344
Self-citationJohnson, R. J., Raines, E. W., Floege, J., Yoshimura, A., Pritzl, P., Alpers, C., & Ross, R. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1413 · Cited by 341
Woolf, A. S., Kolatsi-Joannou, M., Hardman, P., Andermarcher, E., Moorby, C., Fine, L. G., Jat, P. S., Noble, M. D., & Gherardi, E. (1995) · The Journal of cell biology · doi:10.1083/jcb.128.1.171 · Cited by 304
Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
Kliem, V., Johnson, R. J., Alpers, C. E., Yoshimura, A., Couser, W. G., Koch, K. M., & Floege, J. (1996) · Kidney International · doi:10.1038/ki.1996.95 · Cited by 281
Increased synthesis of extracellular matrix in mesangial proliferative nephritis
Floege, J., Johnson, R. J., Gordon, K., Iida, H., Pritzl, P., Yoshimura, A., Campbell, C., Alpers, C. E., & Couser, W. G. (1991) · Kidney International · doi:10.1038/ki.1991.235 · Cited by 264
Tang, W. W., Ulich, T., Lacey, D., Hill, D., Qi, M., Kaufman, S. A., Van, G. Y., Tarpley, J. E., & Yee, J. (1996) · Europe PMC (PubMed Central) · Cited by 226
YAEKASHIWA, M., NAKAYAMA, S., OHNUMA, K., SAKAI, T., ABE, T., SATOH, K., MATSUMOTO, K., NAKAMURA, T., TAKAHASHI, T., & NUKIWA, T. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.6.9611057 · Cited by 207
Self-citationHepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats
Miller, S. B., Martin, D. R., Kissane, J., & Hammerman, M. R. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.1.f129 · Cited by 203
Matsuda, Y., Matsumoto, K., Yamada, A., Ichida, T., Asakura, H., Komoriya, Y., Nishiyama, E., & Nakamura, T. (1997) · Hepatology · doi:10.1002/hep.510260111 · Cited by 198
Self-citationRenotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy.
Nagaike, M., Hirao, S., Tajima, H., Noji, S., Taniguchi, S., Matsumoto, K., & Nakamura, T. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54419-7 · Cited by 196
Self-citationMatsuda, Y., Matsumoto, K., Nakamura, T., & Ichida, T. (1995) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124958 · Cited by 175
Self-citationAlpers, C. E., Hudkins, K. L., Floege, J., & Johnson, R. J. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v52201 · Cited by 166
Progression of Renal Disease and Renal Hypertrophy
Hostetter, T. H. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.001403 · Cited by 166
Antifibrogenic Effect of A Deletion Variant of Hepatocyte Growth Factor on Liver Fibrosis in Rats
Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T., & Higashio, K. (1996) · Hepatology · doi:10.1002/hep.510240328 · Cited by 162
Shiota, G., Wang, T. C., Nakamura, T., & Schmidt, E. V. (1994) · Hepatology · doi:10.1002/hep.1840190423 · Cited by 150
Self-citationTakayama, H., LaRochelle, W. J., Sabnis, S. G., Otsuka, T., & Merlino, G. T. (1997) · PubMed · Cited by 78
Yo, Y., Morishita, R., Yamamoto, K., Tomita, N., Kida, I., Hayashi, S.-I., Moriguchi, A., Kato, S.-I., Matsumoto, K., Nakamura, T., et al. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00726.x · Cited by 66
Self-citationDirect podocyte damage in the single nephron leads to albuminuria in vivo
Laurens, W., Battaglia, C., Foglieni, C., Vos, R. D., Malanchini, B., Damme, B. V., Vanrenterghem, Y. F. C., Remuzzi, G., & Remuzzi, A. (1995) · Kidney International · doi:10.1038/ki.1995.154 · Cited by 49
Cited by
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
TGF-β and epithelial-to-mesenchymal transitions
Zavadil, J., & Böttinger, E. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208927 · Cited by 1,578
Molecular basis of renal fibrosis
Eddy, A. A. (2000) · Pediatric Nephrology · doi:10.1007/s004670000461 · Cited by 637
NAKAMURA, T., & MIZUNO, S. (2010) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.86.588 · Cited by 547
Self-citationMyocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10226 · Cited by 434
Self-citation
Metadata
- Authors
- Mizuno, S., Kurosawa, T., Matsumoto, K., Mizuno-Horikawa, Y., Okamoto, M., & Nakamura, T.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-05-01
- Volume
- 101
- Issue
- 9
- Pages
- 1827-1834
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2002869143
- Cited by
- 254
- References
- 32
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.